Detroit Free Press Interviews IACP's David Miller
IACP is continuing to work with the media on our members' behalf to help raise awareness of compounding and why it's important to preserve patient access. Here is an excerpt from the Detroit Free Press, featuring IACP's David G. Miller, RPh, EVP/CEO.
But other groups, like the trade group International Academy of Compounding Pharmacists, have argued that while changes are needed, federal authority over traditional compounders should not usurp state laws.
The Senate bill would create a new class of drug manufacturers — the House bill calls them “outsourcers” — but it would put in place a list of drugs that could not be compounded, and set deadlines for compounding pharmacies to receive the names of patients receiving their drugs.
“We need to ensure that tragedies like NECC never happen again,” said David Miller, executive vice president and CEO of the compounding pharmacists group. “Unfortunately, over on the Senate side, they decided to go further and get into what pharmacists are allowed to do in their day-to-day practices.”